[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=B-cell;
DOI=10.1074/jbc.272.17.11452; PubMed=9111057 [NCBI, ExPASy, EBI, Israel, Japan]
Carver L.A.,
Bradfield C.A.;
"Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo.";
J. Biol. Chem. 272:11452-11456(1997).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-228.
TISSUE=Lymphoma;
DOI=10.1093/nar/24.23.4741; PubMed=8972861 [NCBI, ExPASy, EBI, Israel, Japan]
Kuzhandaivelu N.,
Cong Y.-S.,
Inouye C.,
Yang W.-M.,
Seto E.;
"XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.";
Nucleic Acids Res. 24:4741-4750(1996).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], INVOLVEMENT IN PAP, AND INVOLVEMENT IN GROWTH HORMONE-SECRETING PITUITARY ADENOMA.
DOI=10.1126/science.1126100; PubMed=16728643 [NCBI, ExPASy, EBI, Israel, Japan]
Vierimaa O.,
Georgitsi M.,
Lehtonen R.,
Vahteristo P.,
Kokko A.,
Raitila A.,
Tuppurainen K.,
Ebeling T.M.L.,
Salmela P.I.,
Paschke R.,
Gundogdu S.,
de Menis E.,
Jaervinen M.J.,
Launonen V.,
Karhu A.,
Aaltonen L.A.;
"Pituitary adenoma predisposition caused by germline mutations in the AIP gene.";
Science 312:1228-1230(2006).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-248, AND MASS SPECTROMETRY.
DOI=10.1038/nbt1046; PubMed=15592455 [NCBI, ExPASy, EBI, Israel, Japan]
Rush J.,
Moritz A.,
Lee K.A.,
Guo A.,
Goss V.L.,
Spek E.J.,
Zhang H.,
Zha X.-M.,
Polakiewicz R.D.,
Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
Nat. Biotechnol. 23:94-101(2005).
|
[6]
|
VARIANTS HIS-16; GLU-241 AND TRP-271, INVOLVEMENT IN GROWTH HORMONE-SECRETING PITUITARY ADENOMA, AND INVOLVEMENT IN FIPA.
DOI=10.1210/jc.2006-2513; PubMed=17244780 [NCBI, ExPASy, EBI, Israel, Japan]
Daly A.F.,
Vanbellinghen J.-F.,
Khoo S.K.,
Jaffrain-Rea M.-L.,
Naves L.A.,
Guitelman M.A.,
Murat A.,
Emy P.,
Gimenez-Roqueplo A.-P.,
Tamburrano G.,
Raverot G.,
Barlier A.,
De Herder W.,
Penfornis A.,
Ciccarelli E.,
Estour B.,
Lecomte P.,
Gatta B.,
Chabre O., ![]()
Sabate M.I.,
Bertagna X.,
Garcia Basavilbaso N.,
Stalldecker G.,
Colao A.,
Ferolla P.,
Wemeau J.-L.,
Caron P.,
Sadoul J.-L.,
Oneto A.,
Archambeaud F.,
Calender A.,
Sinilnikova O.,
Montanana C.F.,
Cavagnini F.,
Hana V.,
Solano A.,
Delettieres D.,
Luccio-Camelo D.C.,
Basso A.,
Rohmer V.,
Brue T.,
Bours V.,
Teh B.T.,
Beckers A.;
"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.";
J. Clin. Endocrinol. Metab. 92:1891-1896(2007).
|
[7]
|
INVOLVEMENT IN PAP.
DOI=10.1210/jc.2006-2394; PubMed=17341560 [NCBI, ExPASy, EBI, Israel, Japan]
Toledo R.A.,
Lourenco D.M. Jr.,
Liberman B.,
Cunha-Neto M.B.C.,
Cavalcanti M.G.,
Moyses C.B.,
Toledo S.P.A.,
Dahia P.L.M.;
"Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.";
J. Clin. Endocrinol. Metab. 92:1934-1937(2007).
|
[8]
|
INVOLVEMENT IN GROWTH HORMONE-SECRETING PITUITARY ADENOMA, AND VARIANT GLN-228.
DOI=10.1210/jc.2006-2702; PubMed=17299063 [NCBI, ExPASy, EBI, Israel, Japan]
Barlier A.,
Vanbellinghen J.-F.,
Daly A.F.,
Silvy M.,
Jaffrain-Rea M.-L.,
Trouillas J.,
Tamagno G.,
Cazabat L.,
Bours V.,
Brue T.,
Enjalbert A.,
Beckers A.;
"Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.";
J. Clin. Endocrinol. Metab. 92:1952-1955(2007).
|
[9]
|
VARIANTS HIS-16 AND GLN-304, INVOLVEMENT IN ACTH-SECRETING PITUITARY ADENOMA, AND INVOLVEMENT IN GROWTH HORMONE-SECRETING PITUITARY ADENOMA.
DOI=10.1073/pnas.0700004104; PubMed=17360484 [NCBI, ExPASy, EBI, Israel, Japan]
Georgitsi M.,
Raitila A.,
Karhu A.,
Tuppurainen K.,
Maekinen M.J.,
Vierimaa O.,
Paschke R.,
Saeger W.,
van der Luijt R.B.,
Sane T.,
Robledo M.,
De Menis E.,
Weil R.J.,
Wasik A.,
Zielinski G.,
Lucewicz O.,
Lubinski J.,
Launonen V.,
Vahteristo P.,
Aaltonen L.A.;
"Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.";
Proc. Natl. Acad. Sci. U.S.A. 104:4101-4105(2007).
|
[10]
|
VARIANT TYR-248 DEL, AND INVOLVEMENT IN GROWTH HORMONE-SECRETING PITUITARY ADENOMA.
DOI=10.1111/j.1365-2265.2008.03266.x; PubMed=18410548 [NCBI, ExPASy, EBI, Israel, Japan]
Georgitsi M.,
De Menis E.,
Cannavo S.,
Maekinen M.J.,
Tuppurainen K.,
Pauletto P.,
Curto L.,
Weil R.J.,
Paschke R.,
Zielinski G.,
Wasik A.,
Lubinski J.,
Vahteristo P.,
Karhu A.,
Aaltonen L.A.;
"Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.";
Clin. Endocrinol. (Oxf.) 0:0-0(2008).
|
|
ExPASy Home page
SIB Switzerland
